Pomdoctor (POM) Stock Overview
Through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
POM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Pomdoctor Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.41 |
| 52 Week High | US$5.53 |
| 52 Week Low | US$3.47 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 34.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| POM | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 16.6% | -5.8% | 0.5% |
| 1Y | n/a | -19.4% | 20.1% |
Return vs Industry: Insufficient data to determine how POM performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how POM performed against the US Market.
Price Volatility
| POM volatility | |
|---|---|
| POM Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: POM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine POM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 156 | Zhenyang Shi | www.7lk.com |
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.
Pomdoctor Limited Fundamentals Summary
| POM fundamental statistics | |
|---|---|
| Market cap | US$640.77m |
| Earnings (TTM) | -US$20.14m |
| Revenue (TTM) | US$48.13m |
Is POM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| POM income statement (TTM) | |
|---|---|
| Revenue | CN¥342.56m |
| Cost of Revenue | CN¥294.86m |
| Gross Profit | CN¥47.69m |
| Other Expenses | CN¥191.05m |
| Earnings | -CN¥143.36m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 13.92% |
| Net Profit Margin | -41.85% |
| Debt/Equity Ratio | -87.7% |
How did POM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 05:17 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pomdoctor Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.